Legge, S E
,
Hamshere, M L
Ripke, S http://orcid.org/0000-0003-3622-835X
Pardinas, A F
Goldstein, J I
Rees, E
Richards, A L
Leonenko, G
Jorskog, L F
Chambert, K D
Collier, D A
Genovese, G
Giegling, I
Holmans, P
Jonasdottir, A
Kirov, G
McCarroll, S A
MacCabe, J H
Mantripragada, K
Moran, J L
Neale, B M
Stefansson, H
Rujescu, D
Daly, M J
Sullivan, P F
Owen, M J
O'Donovan, M C
Walters, J T R
Article History
Received: 21 January 2016
Revised: 10 May 2016
Accepted: 17 May 2016
First Online: 12 July 2016
Competing interests
: LFJ has received research grant support from Teva/Auspex Pharmaceuticals and has served on a Data Safety and Monitoring Board for Janssen. DAC is a full-time employee and stockholder of Eli Lilly and Company. The remaining authors declare no conflicts of interest.